Diosynth is a company that develops manufacturing processes for active ingredients for pharmaceutical companies all over the world. The company started in 1923 with the extraction of insulin from bovine pancreas, which is still one of their main products. As of January 1st, 2005, this company will be part of Organon.
External links
Company website (http://www.diosynth.com)
A request has been made on Wikipedia for this article to be deleted. This request is being discussed to form a consensus whether this is, or could be, an article appropriate for Wikipedia. Please see this page's entry on the votes for deletion page for details. Also see possible outlets for removed articles. If you feel deletion is not justified by Wikipedia deletion policy you may vote against its deletion. Please do not remove this notice or blank this page while the question is being considered. However, you are welcome to continue editing this article and improve it, especially if you can address the concerns of those who believe the article should be deleted.
Diosynth, a business unit of Akzo Nobel, is a science-driven and technology-based manufacturer of complex active pharmaceutical ingredients.
Diosynths operations are backed by a large development organization, strong commitment to Good Manufacturing Practice (cGMP) and strict adherence to HSE legislation.
Diosynth is headquartered in Oss, the Netherlands, has about 2,700 employees and achieved sales in 2003 of EUR 479 million.
One of the world’s largest manufacturers of active pharmaceutical ingredients, Diosynth has established an enviable reputation as a reliable partner in process development and manufacturing for the pharmaceutical sector.
Renowned in the market for its expertise in complex organic chemistry and extractions, Diosynth’s products are used by pharmaceutical companies in the manufacture of drugs to treat a wide variety of ailments and diseases including diabetes, inflammation, hormone deficiency and cancer.
Diosynth BIotechnology facilities in the U.S and Europe manufacture both commercial drug substance and clinical material for leading biotechnology companies around the world.
Feeds |
Contact